N. Steeghs
1 Papers
N. Steeghs is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has co-authored 1 publications.
Chat about Author
Papers
Actualisation des données de phase I de recherche de dose et premières données de la phase d’expansion du tarlatamab, un anticorps bispécifique ciblant la protéine DLL3 et engageant les lymphocytes T, dans le cancer bronchique à petites cellules (CBPC)
Stéphane Champiat,Hirohiko Izumi,Hossein Borghaei,T. Owonikoko,Vicky Lai,M. Christine Boyer,Heinrich Hummel,Ramaswamy Govindan,N. Steeghs,Fiona H Blackhall,Noemi Reguart,A. Dowlati,K. Ouali,Y. Zhang,A. Goldrick,Sutapa Mukherjee,Luis Paz-Ares +16 more
TL;DR: In this paper , le tarlatamab (0,003-100 mg) was administered to patients with or without palier de dose to induce a lyse tumorale médiée by the lymphocytes T (LT).